As PARP4 copy number loss was associated with EGFR and KRAS mutations, we selected two additional classic lung cancer cell lines bearing EGFR or KRAS mutations that had moderate basal PARP4 expression (Fig. 1L). The gene discussed is KRAS; the disease is lung cancer.